| A | B |
|---|
| accelerated bypertension | markedly elevated blood pressure accompanied by hemorrhages and exudates in the eyes |
| diastolic blood pressure | arterial pressure during ventricular relaxation |
| essential hypertension | sustained elevated blood pressure with no known cause |
| hypernatremia | elevated serum sodium level; contributing factor to essential hypertension by increasing blood volume |
| hypertension | sustained elevation of systolic arterial blood pressure of 140 mmHg or higher, a sustained diastolic arterial blood pressure of 90 mmHg or higher, or both |
| hypertensive cardiovascular disease | stage of hypertension when elevated blood pressure causes both cardiac abnormality and vascular damage |
| hypertensive heart disease | stage of hypertensions when elevated blood pressure causes vascular damage without heart involvement |
| hypertensive vascular disease | stage of hypertension when elevated blood pressure causes vascular damage without heart involvement |
| malignant hypertension | dangerously elevated blood pressure accompanied by palpilledema |
| natriuretic factor | hromone produced by the heart, a deficiency of which causes arteries and arterioles to remain in a state of sustained vasoconstriction; elevates BP because its role is to promote excretion of sodium by the kidneys |
| papilledema | swelling of the optic nerve |
| prehypertension | systolic blood pressure of 120-139 mmHg or diastolic blood pressure between 80-89 mmHg |
| secondary hypertension | elevated blood pressure that results from some other disorder |
| stage 1 hypertension | systolic blood pressure of 140-150 mmHg or diastolic blood pressure between 90-99 mmHg |
| stage 2 hypertension | systolic blood pressure that equals or exceeds 160 mmHg or diastolic pressure that equals or exceeds 100 mmHg |
| systolic blood pressure | arterial pressure during ventricular contraction |
| white-coat hypertension | elevated blood pressure that develops during evaluation by medical personnel as a result of anxiety |
